- Implied Volatility 9.64% ( -0.26%)
- Historical Volatility 9.06%
- IV Percentile 49%
- IV Rank 29.03%
- IV High 15.31% on 03/15/23
- IV Low 7.32% on 09/18/23
- Put/Call Vol Ratio 1.79
- Today's Volume 13,362
- Volume Avg (30-Day) 13,452
- Put/Call OI Ratio 0.68
- Today's Open Interest 251,976
- Open Int (30-Day) 262,828
Price PerformanceSee More
|Period||Period Low||Period High||Performance|
| || |
+1.96 (+2.13%)since 11/08/23
| || |
+0.44 (+0.47%)since 09/08/23
| || |
-4.63 (-4.70%)since 12/08/22
Most Recent StoriesMore News
Earlier this month, Goldman Sachs’ head of asset allocation research opined that bonds are becoming ...
Traditionally reliable, the 60/40 portfolio may no longer guarantee solid returns amid concerns about rising interest rates and rising bond yields.
The Fed's July meeting starts today and most traders expect a 25-basis point rate hike. Could Fed Chair Jerome Powell play the rally-killer yet again, or give traders more reasons to buy?
The global ETF assets could top $11 trillion by 2027. Fixed-income ETFs are expected to remain the top contributor, growing substantially faster than any other asset class.
Wall Street witnessed a decent March despite heightened volatility created by bank failures in the United States and Europe. A flight-to-safety led investors to flock to safe-haven U.S. Treasuries in the...
Overall, ETFs pulled in $76.9 billion capital in the first quarter.
T-bills may be the flavor of the month, but history has shown this top biotech stock is a far better long-term investment.
The banking crisis has shaken the global markets since Mar 9. These ETF areas amassed maximum cash during the peak of the crisis.
Inflows to dividend ETFs were noteworthy last week.